OFATUMUMAB vs OLMESARTAN MEDOXOMIL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OFATUMUMAB vs OLMESARTAN MEDOXOMIL: Safety Overview
| Metric | OFATUMUMAB | OLMESARTAN MEDOXOMIL |
|---|---|---|
| Total FAERS Reports | 29,913 | 11,972 |
| Deaths Reported | 695 | 283 |
| Death Rate | 2.3% | 2.4% |
| Hospitalizations | 3,616 | 6,564 |
| Average Patient Age | 47.5 yrs | 66.9 yrs |
| % Female Patients | 74.9% | 56.6% |
| FDA Approval Date | N/A | Apr 13, 2020 |
| Manufacturer | Novartis Pharmaceuticals Corporation | direct rx |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |